Upregulation of miR-340-5p reverses cisplatin sensitivity by inhibiting the expression of CDK6 in HepG2 cells

• Autorzy: Tian S. , Liu Z. , Zhou Q. , Wu R. , Huang X. , Liang Z. , Zhang Z. , Tian X.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

cisplatin; chemotherapy; liver cancer; HepG2 cell; miR-340-5p; CDK6; drug resistance

• Wydawca: -
• Czasopismo: Folia Biologica
• Rocznik: 2021
• Tom: 69
• Numer: 2
• Opis fizyczny: p.57-66,fig.,ref.

Twórcy

autor

Tian S.

• College of Integrated Chinese and Western Medicine of the Hunan University of Chinese Medicine, 300 Xuanpu Science and Education Yuan, Yuelu District, Changsha, Hunan, 410208, China

autor

Liu Z.

• Hunan Institute of Traditional Chinese Medicine, Changsha, Hunan, China

autor

Zhou Q.

• The First Hospital of the Hunan University of Chinese Medicine, Changsha, Hunan, China

autor

Wu R.

• College of Integrated Chinese and Western Medicine of the Hunan University of Chinese Medicine, 300 Xuanpu Science and Education Yuan, Yuelu District, Changsha, Hunan, 410208, China

autor

Huang X.

• College of Integrated Chinese and Western Medicine of the Hunan University of Chinese Medicine, 300 Xuanpu Science and Education Yuan, Yuelu District, Changsha, Hunan, 410208, China

autor

Liang Z.

• College of Integrated Chinese and Western Medicine of the Hunan University of Chinese Medicine, 300 Xuanpu Science and Education Yuan, Yuelu District, Changsha, Hunan, 410208, China

autor

Zhang Z.

• College of Integrated Chinese and Western Medicine of the Hunan University of Chinese Medicine, 300 Xuanpu Science and Education Yuan, Yuelu District, Changsha, Hunan, 410208, China

autor

Tian X.

• College of Integrated Chinese and Western Medicine of the Hunan University of Chinese Medicine, 300 Xuanpu Science and Education Yuan, Yuelu District, Changsha, Hunan, 410208, China

Identyfikatory

DOI

10.3409/fb_69-2.08